@article{Lee_L-2020_7312,
title = {COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study},
author = {Lee, L. and Cazier, J. and Starkey, T. and Briggs, S. and Arnold, R. and Bisht, V. and Booth, S. and Campton, N. and Cheng, V. and Collins, G. and Curley, H. and Earwaker, P. and Fittall, M. and Gennatas, S. and Goel, A. and Hartley, S. and Hughes, D. and Kerr, D. and Lee, A. and Lee, R. and Lee, S. and McKenzie, H. and Middleton, C. and Murugaesu, N. and Newsom-Davies, T. and Olosson-Brown, A. and Palles, C. and Powles, T. and Protheroe, E. and Purshouse, K. and Sharma-Oates, A. and Sivakumar, S. and Smith, A. and Topping, O. and Turnbull, C. and Várnai, C. and Briggs, A. and Middleton, G.},
month = {oct},
year = {2020},
abstract = {BACKGROUND: Patients with cancer are purported to have poor COVID-19 outcomes. However, cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour subtypes. The aim of this study was to investigate COVID-19 risk according to tumour subtype and patient demographics in patients with cancer in the UK.},
pages = {E1309-E1316},
volume = {21},
issue = {10},
journal = {Lancet Oncology},
publisher = {Elsevier},
url = {https://doi.org/10.1016/S1470-2045(20)30442-3},
}
